在不成比例的风险下治疗效果的措施
Dan Jackson1, Michael Sweeting1, Rose Baker2
1Statistical Innovation, AstraZeneca, Cambridge, UK.
Pharmaceutical statistics
|October 27, 2024
概括
本评论澄清了在不成比例的危险下对时间到事件数据的新型治疗效果估计器. 它旨在促进对缓解对临床试验准确分析的比例危险假设的方法的讨论.
科学领域:
- 生物统计学 生物统计学
- 临床试验 临床试验
- 生存分析的分析.
背景情况:
- 相对危险假设是分析时间到事件数据的常见限制.
- 提出了新的治疗效果估计器,以解决不成比例的危险.
- 需要澄清这些估计器的属性,以便进行可靠的应用.
研究的目的:
- 阐明Snapinn等人提出的新型治疗效果估计器的特性.
- 为了解决有关这些估计者的具体澄清问题.
- 鼓励对不依赖比例危险的治疗效果措施进行进一步的研究.
主要方法:
- 该研究提供了对现有的统计方法的评论和澄清.
- 专注于提出的估计器的理论特性.
- 没有产生新的数据;分析是基于现有的文献.
主要成果:
- 澄清了关于新型估计器属性的三个关键点.
- 评论旨在增强对估计者的行为的理解.
- 讨论强调了解决不成比例风险的重要性.
结论:
- 澄清这些估计器有助于它们的适当应用.
- 进一步讨论不成比例危险方法是有必要的.
- 这项工作有助于推进临床试验生存分析的统计方法.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91
Kaplan-Meier Approach
102
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
102
Introduction To Survival Analysis
184
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
184
Hazard Rate
91
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
91
Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97


